C
Cellics Therapeutics
Cellics is committed to saving lives and improving patients’ health using innovative biomimetic nanomedicines
About Cellics Therapeutics
Cellics Therapeutics is a biopharmaceutical company based in San Diego, CA, specializing in the development of advanced nano therapeutics through its proprietary Cellular Nanoparticle platform technology. The company serves clients in the healthcare and pharmaceutical sectors, focusing on the treatment of complex diseases. Cellics operates in the biopharmaceutical market and employs a business model centered on research and development, collaboration with industry leaders, and potential licensing agreements. Revenue is generated through partnerships, grants, and potential future sales of developed therapeutics. The core technology, Cellular Nanosponges, utilizes cell membranes to create specialized nanoparticles aimed at improving therapeutic outcomes. The company is led by a team of experienced life sciences professionals and was founded by UC San Diego Professor Liangfang Zhang.
Source: Dealroom company dataAt a glance
- Founded
- 2014
- Headquarters
- San Diego, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
CARB-X
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cellics Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cellics Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.